FDA Approved: DAPTOMYCIN IN SODIUM CHLORIDE — Supplemental Application (Baxter Healthcare Corporation)

View source ↗

Summary

FDA approved a supplemental application for Daptomycin in Sodium Chloride from Baxter, authorizing a saline formulation of the antibiotic.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacteremia
• Complicated Skin and Skin Structure Infections
• Infective Endocarditis

Drugs mentioned

• Daptomycin in Sodium Chloride (Daptomycin)

Snippet

SUPPL AP for DAPTOMYCIN IN SODIUM CHLORIDE (DAPTOMYCIN IN SODIUM CHLORIDE)